VE303, a defined bacterial consortium, for prevention of recurrent Clostridioides difficile infection: a randomized clinical trial T Louie, Y Golan, S Khanna, D Bobilev, N Erpelding, C Fratazzi, M Carini, ... Jama 329 (16), 1356-1366, 2023 | 79 | 2023 |
Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers M Dsouza*, R Menon*, E Crossette, SK Bhattarai, J Schneider, YG Kim, ... Cell, Host & Microbe 30 (4), 583-598.E8, 2022 | 79 | 2022 |
Microbiota profile in new-onset pediatric Crohn’s disease: data from a non-Western population MI El Mouzan, HS Winter, AA Assiri, KS Korolev, AA Al Sarkhy, SE Dowd, ... Gut Pathogens 10, 1-10, 2018 | 46 | 2018 |
Public good diffusion limits microbial mutualism R Menon, KS Korolev Physical review letters 114 (16), 168102, 2015 | 46 | 2015 |
Fungal microbiota profile in newly diagnosed treatment-naive children with Crohn’s disease M El Mouzan, F Wang, M Al Mofarreh, R Menon, A Al Barrag, KS Korolev, ... Journal of Crohn's and Colitis 11 (5), 586-592, 2017 | 40 | 2017 |
Interactions between species introduce spurious associations in microbiome studies R Menon, V Ramanan, KS Korolev PLoS computational biology 14 (1), e1005939, 2018 | 32 | 2018 |
Fungal dysbiosis predicts the diagnosis of pediatric Crohn’s disease MI El Mouzan, KS Korolev, MA Al Mofarreh, R Menon, HS Winter, ... World journal of gastroenterology 24 (39), 4510, 2018 | 20 | 2018 |
1953. VE303, a Rationally Designed Bacterial Consortium for Prevention of Recurrent Clostridioides difficile (C. Difficile) infection (rCDI), Stably Restores the Gut … D Bobilev, S Bhattarai, R Menon, B Klein, S Reddy, B Olle, B Roberts, ... Open Forum Infectious Diseases 6 (Supplement_2), S60-S60, 2019 | 16 | 2019 |
Randomized, double-blind, placebo (PBO)-controlled, single-and multiple-dose phase 1 study of VE202, a defined bacterial consortium for treatment of IBD: safety and … J Silber, J Norman, T Kanno, E Crossette, R Szabady, R Menon, M Marko, ... Inflammatory Bowel Diseases 28 (Supplement_1), S65-S66, 2022 | 7 | 2022 |
Fungal microbiota profile in newly diagnosed treatment-naïve children with Crohn's disease. J Crohn’s Colitis. 2017; 11 (5): 586–92 M El Mouzan, F Wang, M Al Mofarreh, R Menon, A Al Barrag, KS Korolev Epub 2016/11/05. https://doi. org/10.1093/ecco-jcc/jjw197 PMID: 27811291, 0 | 5 | |
Bacterial dysbiosis predicts the diagnosis of Crohn's disease in Saudi children MI El Mouzan, HS Winter, AA Al Sarkhy, K Korolev, R Menon, AA Assiri Saudi Journal of Gastroenterology 27 (3), 144-148, 2021 | 2 | 2021 |
Faecal Microbiota Transplantation Engraftment After Budesonide or Placebo in Patients With Active Ulcerative Colitis Using Pre-selected Donors: A Randomized Pilot Study E van Lingen, S Nooij, EM Terveer, E Crossette, AL Prince, SK Bhattarai, ... Journal of Crohn's and Colitis, jjae043, 2024 | 1 | 2024 |
Reddy, 1359 S.; Caballero, S.; Felix, C.; Cornacchione, L. Colonization of the live biotherapeutic product 1360 VE303 and modulation of the microbiota and metabolites in … M Dsouza, R Menon, E Crossette, SK Bhattarai, J Schneider, YG Kim Cell Host & 1361 Microbe 30, 583-598, 2022 | 1 | 2022 |
Methods of decreasing dysbiosis and restoring a microbiome J Norman | 1 | 2020 |
43 RECOVERY OF MICROBIOME FUNCTIONAL PATHWAYS INVOLVED IN STICKLAND FERMENTATION IN PATIENTS RECEIVING VE303, A DEFINED BACTERIAL CONSORTIUM FOR CLOSTRIDIOIDES DIFFICILE … EM Crossette, R Menon, A Watson, WA Chen, G Medlock, AL Prince, ... Gastroenterology 166 (5), S-17, 2024 | | 2024 |
2140. Biological Features of Response to VE303, a Defined Bacterial Consortium, in Patients with Clostridioides difficile Infection (CDI): Results from the Phase 2 CONSORTIUM Study R Menon, E Crossette, S Bhattarai, V Bucci, AL Prince, J Faith, B Olle, ... Open Forum Infectious Diseases 10 (Suppl 2), 2023 | | 2023 |
695 PHARMACODYNAMIC RESPONSE TO A DEFINED BACTERIAL CONSORTIUM, VE303, IN PATIENTS WITH CLOSTRIDIOIDES DIFFICILE INFECTION (CDI): RESULTS OF THE PHASE 2 CONSORTIUM STUDY R Menon, EM Crossette, S Bhattarai, V Bucci, J Faith, B Olle, JL Silber, ... Gastroenterology 164 (6), S-141, 2023 | | 2023 |
METHODS OF REDUCING DYSBIOSIS AND RESTORING A MICROBIOME J Norman, B Olle, B Roberts, R MENON | | 2022 |
890: RAPID AND DURABLE COLONIZATION OF VE303 IN CLOSTRIDIODES DIFFICILE INFECTION (CDI) PATIENTS IS ASSOCIATED WITH CLINICAL EFFICACY: RESULTS OF THE PHASE 2 CONSORTIUM STUDY R Menon, EM Crossette, S Bhattarai, V Bucci, J Faith, M Ruisi, B Olle, ... Gastroenterology 162 (7), S-217, 2022 | | 2022 |
468: DURABLE COLONIZATION OF THE RATIONALLY DESIGNED LIVE BIOTHERAPEUTIC PRODUCTS VE202 AND VE818 IN HEALTHY VOLUNTEERS EM Crossette, R Menon, ES Lamousé-Smith, T Kanno, LY Hao, A Prince, ... Gastroenterology 162 (7), S-107-S-108, 2022 | | 2022 |